Literature DB >> 33683164

Nanotechnology against the novel coronavirus (severe acute respiratory syndrome coronavirus 2): diagnosis, treatment, therapy and future perspectives.

Hamid Rashidzadeh1,2, Hossein Danafar2,3, Hossein Rahimi2, Faezeh Mozafari2, Marziyeh Salehiabar4, Mohammad Amin Rahmati2, Samaneh Rahamooz-Haghighi5, Navid Mousazadeh2, Ali Mohammadi2, Yavuz Nuri Ertas6,7, Ali Ramazani1, Irada Huseynova8, Rovshan Khalilov3,9,10, Soodabeh Davaran3,4, Thomas J Webster11, Taras Kavetskyy3,12,13, Aziz Eftekhari14,12,10,15, Hamed Nosrati2,3, Mehdi Mirsaeidi16.   

Abstract

COVID-19, as an emerging infectious disease, has caused significant mortality and morbidity along with socioeconomic impact. No effective treatment or vaccine has been approved yet for this pandemic disease. Cutting-edge tools, especially nanotechnology, should be strongly considered to tackle this virus. This review aims to propose several strategies to design and fabricate effective diagnostic and therapeutic agents against COVID-19 by the aid of nanotechnology. Polymeric, inorganic self-assembling materials and peptide-based nanoparticles are promising tools for battling COVID-19 as well as its rapid diagnosis. This review summarizes all of the exciting advances nanomaterials are making toward COVID-19 prevention, diagnosis and therapy.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; coronavirus; diagnosis; nanotechnology; treatment

Mesh:

Substances:

Year:  2021        PMID: 33683164      PMCID: PMC7938776          DOI: 10.2217/nnm-2020-0441

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  133 in total

Review 1.  Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.

Authors:  Susan R Weiss; Sonia Navas-Martin
Journal:  Microbiol Mol Biol Rev       Date:  2005-12       Impact factor: 11.056

2.  Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization.

Authors:  Veit Hornung; Franz Bauernfeind; Annett Halle; Eivind O Samstad; Hajime Kono; Kenneth L Rock; Katherine A Fitzgerald; Eicke Latz
Journal:  Nat Immunol       Date:  2008-07-11       Impact factor: 25.606

3.  In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.

Authors:  Hamid Rashidzadeh; Mahsa Salimi; Somayeh Sadighian; Kobra Rostamizadeh; Ali Ramazani
Journal:  Curr Drug Deliv       Date:  2019       Impact factor: 2.565

4.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

5.  Viromimetic STING Agonist-Loaded Hollow Polymeric Nanoparticles for Safe and Effective Vaccination against Middle East Respiratory Syndrome Coronavirus.

Authors:  Leon Chien-Wei Lin; Chen-Yu Huang; Bing-Yu Yao; Jung-Chen Lin; Anurodh Agrawal; Abdullah Algaissi; Bi-Hung Peng; Yu-Han Liu; Ping-Han Huang; Rong-Huay Juang; Yuan-Chih Chang; Chien-Te Tseng; Hui-Wen Chen; Che-Ming Jack Hu
Journal:  Adv Funct Mater       Date:  2019-04-12       Impact factor: 18.808

6.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.

Authors:  Jasper Fuk-Woo Chan; Shuofeng Yuan; Kin-Hang Kok; Kelvin Kai-Wang To; Hin Chu; Jin Yang; Fanfan Xing; Jieling Liu; Cyril Chik-Yan Yip; Rosana Wing-Shan Poon; Hoi-Wah Tsoi; Simon Kam-Fai Lo; Kwok-Hung Chan; Vincent Kwok-Man Poon; Wan-Mui Chan; Jonathan Daniel Ip; Jian-Piao Cai; Vincent Chi-Chung Cheng; Honglin Chen; Christopher Kim-Ming Hui; Kwok-Yung Yuen
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 7.  Comprehensive Review on Current Interventions, Diagnostics, and Nanotechnology Perspectives against SARS-CoV-2.

Authors:  Deepak S Chauhan; Rajendra Prasad; Rohit Srivastava; Meena Jaggi; Subhash C Chauhan; Murali M Yallapu
Journal:  Bioconjug Chem       Date:  2020-08-12       Impact factor: 4.774

8.  Recombinant canine coronaviruses in dogs, Europe.

Authors:  Nicola Decaro; Viviana Mari; Gabriella Elia; Diane D Addie; Michele Camero; Maria Stella Lucente; Vito Martella; Canio Buonavoglia
Journal:  Emerg Infect Dis       Date:  2010-01       Impact factor: 6.883

9.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.

Authors:  Markus Hoffmann; Hannah Kleine-Weber; Simon Schroeder; Nadine Krüger; Tanja Herrler; Sandra Erichsen; Tobias S Schiergens; Georg Herrler; Nai-Huei Wu; Andreas Nitsche; Marcel A Müller; Christian Drosten; Stefan Pöhlmann
Journal:  Cell       Date:  2020-03-05       Impact factor: 41.582

View more
  12 in total

Review 1.  Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity.

Authors:  Gandarvakottai Senthilkumar Arumugam; Kannan Damodharan; Mukesh Doble; Sathiah Thennarasu
Journal:  Mol Biomed       Date:  2022-07-15

Review 2.  Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs.

Authors:  Nunzio Iraci; Carmelo Corsaro; Salvatore V Giofrè; Giulia Neri; Angela Maria Mezzasalma; Martina Vacalebre; Antonio Speciale; Antonina Saija; Francesco Cimino; Enza Fazio
Journal:  Biomolecules       Date:  2022-07-30

Review 3.  Nanomedicine to deliver biological macromolecules for treating COVID-19.

Authors:  Barnabas Wilson; Kannoth Mukundan Geetha
Journal:  Vaccine       Date:  2022-05-30       Impact factor: 4.169

4.  Influenza Vaccine Utilization: A Comparison between Urban and Rural Counties in Florida.

Authors:  Abdullah A Alalwan
Journal:  Vaccines (Basel)       Date:  2022-04-23

Review 5.  Nanoparticles for Coronavirus Control.

Authors:  Maryam Kianpour; Mohsen Akbarian; Vladimir N Uversky
Journal:  Nanomaterials (Basel)       Date:  2022-05-09       Impact factor: 5.719

Review 6.  A review on the recent achievements on coronaviruses recognition using electrochemical detection methods.

Authors:  Ezat Hamidi-Asl; Leyla Heidari-Khoshkelat; Jahan Bakhsh Raoof; Tara P Richard; Siamak Farhad; Milad Ghani
Journal:  Microchem J       Date:  2022-02-25       Impact factor: 4.821

Review 7.  Anti-COVID-19 Nanomaterials: Directions to Improve Prevention, Diagnosis, and Treatment.

Authors:  Mohammad Souri; Mohsen Chiani; Ali Farhangi; Mohammad Reza Mehrabi; Dariush Nourouzian; Kaamran Raahemifar; M Soltani
Journal:  Nanomaterials (Basel)       Date:  2022-02-25       Impact factor: 5.076

8.  Identifying a New Social Intervention Model of Panic Buying Under Sudden Epidemic.

Authors:  Peihua Fu; Bailu Jing; Tinggui Chen; Jianjun Yang; Guodong Cong
Journal:  Front Public Health       Date:  2022-03-11

9.  Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses.

Authors:  Ramireddy Bommireddy; Shannon Stone; Noopur Bhatnagar; Pratima Kumari; Luis E Munoz; Judy Oh; Ki-Hye Kim; Jameson T L Berry; Kristen M Jacobsen; Lahcen Jaafar; Swe-Htet Naing; Allison N Blackerby; Tori Van der Gaag; Chloe N Wright; Lilin Lai; Christopher D Pack; Sampath Ramachandiran; Mehul S Suthar; Sang-Moo Kang; Mukesh Kumar; Shaker J C Reddy; Periasamy Selvaraj
Journal:  Vaccines (Basel)       Date:  2022-06-14

Review 10.  Use of Protamine in Nanopharmaceuticals-A Review.

Authors:  Ivana Ruseska; Katja Fresacher; Christina Petschacher; Andreas Zimmer
Journal:  Nanomaterials (Basel)       Date:  2021-06-07       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.